Britain city Sanofi vaccine business Coronavirus Britain city Sanofi

GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

Reading now: 464
www.rte.ie

GlaxoSmithKline will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for Covid-19, the British drugmaker said today.

The company said it was in talks with governments on backing for the programme, which would effectively allow for a scaling up of production of future successful vaccines for the disease caused by the coronavirus.

GSK is one of several companies in the race to develop a vaccine for the respiratory illness that currently has no treatment and has already killed about 350,000 people.

The London-listed drugmaker is working on its own Covid vaccine with Sanofi. Adjuvants have been shown to create a stronger and longer-lasting immunity against infections.

Read more on rte.ie
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA